5 big analyst AI moves: Nvidia guidance warning; Snowflake, Palo Alto upgraded
On Wednesday, Craig-Hallum analyst Greg Palm adjusted the price target for Transcat Inc. (NASDAQ:TRNS), a leading provider of calibration, repair, inspection, and laboratory instrument services, to $94.00, down from the previous target of $125.00. The stock, currently trading at $85.35 with a market cap of $800.69 million, has seen analyst targets ranging from $94 to $130. According to InvestingPro analysis, the stock appears to be trading above its Fair Value. Despite the reduction, the analyst maintained a Buy rating on the stock.
Transcat’s recent quarterly earnings report fell short of expectations, leading to another downward revision of its earnings forecast. The stock has taken a significant hit, declining 16.5% over the past week and 36% over the last six months, as noted by InvestingPro, which offers 12 additional valuable insights about the company’s performance. The disappointing performance this quarter was attributed to the timing of the holidays and the deferral of service work from December into January, rather than issues solely within its Solutions business, formerly known as Nexa.
The earnings miss, however, overshadowed the positive news of Transcat’s acquisition of Martin Calibration, which was completed in December. The analyst believes the acquisition is highly strategic, meeting all the necessary criteria to yield significant synergies for the company.
Although the current outlook suggests that Transcat’s stock may experience limited movement in the short term as it works towards regaining more normalized growth rates, Craig-Hallum’s analysis remains optimistic about the company’s long-term growth prospects. The firm encourages patient investors, suggesting they could still see favorable returns over time despite the near-term challenges faced by Transcat.
In other recent news, Transcat Inc. recently reported its third fiscal quarter 2025 results, which fell short of expectations with revenues of $66.8 million. Additionally, the company’s organic service revenue saw a 3.8% decline, leading to a revision of its full-year 2025 organic service growth outlook. Despite these results, analyst firm H.C. Wainwright maintained a Buy rating for the company, citing positive indicators such as stronger activity levels in January and the recent acquisition of Martin Calibration Inc.
Oppenheimer analysts, however, downgraded Transcat’s stock from Outperform to Perform, following the less than expected results. Transcat also entered into severance agreements with three of its top executives, providing leadership stability for potential future mergers or acquisitions.
Craig-Hallum responded positively to the acquisition of Martin Calibration, upgrading Transcat’s price target from $113.00 to $125.00. In the second quarter of fiscal 2025, Transcat reported an 8% increase in consolidated revenue, largely due to strong demand in calibration services and the rental business. These are among the recent developments in Transcat’s ongoing efforts to improve operational efficiencies and capitalize on market opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.